IRIS
AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.574
NA - Nord America 1.147
EU - Europa 534
SA - Sud America 91
AF - Africa 15
OC - Oceania 8
Totale 7.369
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.720
US - Stati Uniti d'America 1.097
CN - Cina 494
HK - Hong Kong 222
GB - Regno Unito 142
IT - Italia 140
DE - Germania 73
BR - Brasile 72
VN - Vietnam 65
FI - Finlandia 48
NL - Olanda 38
CA - Canada 28
TR - Turchia 21
IN - India 20
MX - Messico 19
PL - Polonia 16
FR - Francia 14
CZ - Repubblica Ceca 10
ES - Italia 10
JP - Giappone 10
LT - Lituania 10
UA - Ucraina 10
AR - Argentina 8
AU - Australia 8
AT - Austria 6
ZA - Sudafrica 6
BD - Bangladesh 4
EC - Ecuador 4
ID - Indonesia 4
PE - Perù 3
RU - Federazione Russa 3
SE - Svezia 3
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
HU - Ungheria 2
MY - Malesia 2
TL - Timor Orientale 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BJ - Benin 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
ML - Mali 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
TN - Tunisia 1
VG - Isole Vergini Britanniche 1
YT - Mayotte 1
Totale 7.369
Salva come PNG Salva come JPEG
Città #
Singapore 326
Dallas 264
Ashburn 217
Hong Kong 217
Hefei 206
London 122
Boardman 115
Beijing 110
Shanghai 71
Council Bluffs 59
Munich 56
West Jordan 40
Los Angeles 37
Rome 35
Amsterdam 30
Ho Chi Minh City 29
Turku 26
Santa Clara 25
San Francisco 23
Washington 23
Helsinki 22
Sona 20
Seattle 19
São Paulo 18
Bari 15
Warsaw 15
Ankara 14
Toronto 13
Pune 12
Mexico City 11
Atlanta 10
Brno 10
Brooklyn 10
Tokyo 10
Hanoi 9
Boston 8
New York 8
Changsha 7
Charlotte 7
Chicago 5
Haiphong 5
Milan 5
Montreal 5
Chengdu 4
Chennai 4
Da Nang 4
Duino-Aurisina 4
Haikou 4
Naples 4
Noicattaro 4
Paris 4
State College 4
Brasília 3
Brest 3
Denver 3
Guayaquil 3
Hải Dương 3
Johannesburg 3
Manchester 3
Ninh Bình 3
Philadelphia 3
Phoenix 3
Redmond 3
San Jose 3
Secaucus 3
Sydney 3
The Dalles 3
Vienna 3
Vilnius 3
Canberra 2
Central 2
Charleston 2
Cuernavaca 2
Curitiba 2
Dili 2
Guiyang 2
Handan 2
Herne Bay 2
Honolulu 2
Lima 2
Linyi 2
Melbourne 2
Messina 2
Montesilvano Marina 2
Orem 2
Perugia 2
Resistencia 2
Reus 2
Ribeirão Preto 2
Rio de Janeiro 2
Rockville 2
Santo André 2
Stockholm 2
Teresina 2
Tianjin 2
Topeka 2
Tây Ninh 2
Abidjan 1
Ajman 1
Almere Stad 1
Totale 2.435
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 207
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 206
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 204
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 203
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 201
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 200
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 198
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 196
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 194
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 190
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 187
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 181
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 181
Leptin in immuno-rheumatological diseases 173
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 111
GH-resistance in different stages of chronic liver disease 110
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 108
Diabetes in chronic liver disease: from old concepts to new evidence 107
Enhanced portal flow velocity and volume following Iloprost treatment 105
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 102
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 101
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 99
Radiofrequency ablation of hepatic tissue: a new experimental animal model 98
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 98
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 96
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 96
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 96
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 95
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 94
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 91
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 89
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 89
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 89
Cannabinoids in Autoimmune and Rheumatic Diseases 88
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 86
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 86
Leptin in autoimmune mechanisms of systemic rheumatic diseases 86
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 83
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 83
ANA testing in ‘real life’ 83
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 79
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 74
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 73
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 69
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 69
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 67
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 64
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 61
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 55
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 51
Pain and Frailty in Hospitalized Older Adults 48
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 46
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 41
TNF-alpha and growth hormone resistance in patients with chronic liver disease 39
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 38
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 36
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 35
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 35
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 35
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 35
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 34
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 34
The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study 33
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 32
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 32
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 32
Matters of the heart: The case of TNF-alpha targeting drugs 32
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 32
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 32
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 32
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 31
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 31
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 30
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 30
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 30
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 29
Surgical complications after resection of adrenal carcinoma 29
Utility of ultrasound in the diagnosis of chronic worsened gout 28
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 28
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 27
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 27
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 27
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 26
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 26
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 26
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 26
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 26
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 26
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 26
Phase angle could be a marker of microvascular damage in systemic sclerosis 26
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 26
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 25
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 25
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 24
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 24
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 24
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 23
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 23
Serum level of endostatin and digital ulcers in systemic sclerosis patients 23
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 23
Totale 7.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20255.517 58 41 143 42 94 123 40 25 265 355 1.874 2.457
2025/20261.209 324 193 331 267 94 0 0 0 0 0 0 0
Totale 7.435